REBOUND HRD

K063671 · Minnesota Medical Development, Inc. · FTL · Aug 16, 2007 · General, Plastic Surgery

Device Facts

• Record ID: K063671
• Device Name: REBOUND HRD
• Applicant: Minnesota Medical Development, Inc.
• Product Code: FTL · General, Plastic Surgery
• Decision Date: Aug 16, 2007
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.3300
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

REBOUND HRD™ is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.

Device Story

Rebound HRD is a self-expanding surgical mesh with a super-elastic, multi-strand Nitinol frame; designed for inguinal and ventral hernia repair. Device is folded into a 10mm loading cannula and inserted laparoscopically through a 10-12mm port; also suitable for open incision placement. Frame provides structural stability, conforming to anatomy and eliminating need for anchoring. Device is placed between fascia and fully closed peritoneum with 15mm margin beyond defect. Used by surgeons in clinical settings. Benefits include simplified placement and secure defect coverage. Device is sterile, single-use, and radiopaque for X-ray detection.

Clinical Evidence

No clinical data. Evidence consists of bench testing (weld, burst strength, deployment, fatigue, MRI compatibility) and animal testing to evaluate device placement, structural integrity, radiopacity, and tissue response.

Technological Characteristics

Polymer surgical mesh with super-elastic, multi-strand Nitinol frame. Dimensions accommodate various hernia types. Sterile, single-use. Radiopaque. Deployed via 10mm loading cannula. No software or electronic components.

Indications for Use

Indicated for patients requiring repair or reinforcement of hernia or soft tissue defects where nonabsorbable support is preferred. No specific age or gender restrictions provided.

Regulatory Classification

Identification

Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.

Predicate Devices

• VITAMESHTM MacroPorous PP Surgical Mesh (K060520)
• Kugel Hernia Patch (K963141)

Submission Summary (Full Text)

{0}------------------------------------------------

## 510(k) Summary

## Submitted on behalf of:

| Company Name: | Minnesota Medical Development, Inc. (MMDI) | AUG 16 200 |
|----------------------|--------------------------------------------------------------------------------------------------------|------------|
| Address: | 14305 21st Avenue North, Suite 100<br>Plymouth, MN 55447 | |
| Telephone: | 763-354-7100 | |
| Fax: | 763-354-7001 | |
| by: | Elaine Duncan, M.S.M.E., RAC<br>President, Paladin Medical, Inc.<br>PO Box 560<br>Stillwater, MN 55082 | |
| Telephone: | 715-549-6035 | |
| Fax: | 715-549-5380 | |
| CONTACT PERSON: | Elaine Duncan | |
| DATE PREPARED: | December 8, 2006 | |
| TRADE NAME: | REBOUND HRDTM hernia mesh device | |
| COMMON NAME: | hernia mesh | |
| CLASSIFICATION NAME: | surgical mesh | |
| PRO CODE: | FTL | |

## SUBSTANTIALLY EQUIVALENT TO:

VITAMESHTM MacroPorous PP Surgical Mesh K060520 and K963141 Kugel Hernia Patch

DESCRIPTION of the DEVICE: The Rebound HRD™ (Hernia Repair Device) is a self-expanding Nitinol framed/surgical mesh designed for the repair of both inguinal and ventral hernias. The Rebound HRD™ is designed for placement, between the fascia and fully closed peritoneum, so that it covers the direct and indirect space with at least a 15mm margin beyond the edges of the hernia defect. The Rebound HRDTM conforms to the anatomy while providing stability; eliminating the need for anchoring. The super-elastic, multi-strand, Nitinol frame allows the device to be folded into the supplied 10mm loading cannula (supplied in the product package) and inserted laparoscopically through a 10-12mm access port. it may also be placed via an open incision approach using the same dissection and positioning methods described for the laparoscopic technique. The Rebound HRD™ is supplied sterile and is designed as a single use device. It is manufactured in several shapes to accommodate different hernia types, anatomies and surgeon preference.

INDICATIONS FOR USE: REBOUND HRD™ is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.

SUMMARY of TESTING: The polymer mesh is the same mesh as submitted in a predicate submission. Therefore the testing concentrated on questions of potential new risks from adding the wire frame. Confirming biocompatibility testing demonstrated that processing and additional materials do not alter the excellent biocompatibility of the basic mesh. Testing included weld testing, burst strength testing on the assembly, deployment of the device through a cannula and fatigue testing. In addition, MRI compatibility testing was conducted to assure MRI compatibility. Animal testing demonstrated the device will stay in place, will stay together when implanted, can be detected via X-ray, and has tissue response typical for this type of implant. Instructions for use were evaluated as well.

| REBOUND HRD™ Hernia Repair Device by MMDI | |
|-------------------------------------------|------------------------|
| 510(k) Submission | Section 5, page 2 of 2 |

{1}------------------------------------------------

Public Health Service

Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird-like figure with three curved lines forming its body and wings. The logo is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 16 2007

Minnesota Medical Development, Inc. % Paladin Medical, Inc. Ms. Elaine Duncan, M.S., RAC President P.O. Box 560 Stillwater, Minnesota 55082-0560

Re: K063671

Trade/Device Name: REBOUND HRD™ (Hernia Mesh Device) Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: FTL Dated: August 1, 2007 Received: August 2, 2007

Dear Ms. Duncan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set

{2}------------------------------------------------

Page 2 - Ms. Elaine Duncan, M.S., RAC

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Mark A. Millman

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

## Indications for Use

510(k) Number (if known):

REBOUND HRD™ (Hernia Mesh Device) Device Name:

Indications For Use:

REBOUND HRD™ is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Mark N. Melkman

(Division Sign-Off) Division of Gener I. Restorative. and Neurological Devices

510(k) Number K063671

Page 1 of __ 1________________________________________________________________________________________________________________________________________________________________